Máté Kiss

FEBS Advanced Lecture Course 2026 - Tumour microenvironment: From tumour heterogeneity to therapy resistance 4–8 May 2026 │ Fodele, Greece

One week left to register for the FEBS Advanced Course on Tumour Microenvironment: From Tumour Heterogeneity to Therapy Resistance. which will be held in May 4-8, 2026, in Crete! 🧑‍🔬 🧪 🔬
There is an excellent line up of internationally recognized speakers!

tumourmicroenvironment2026.febsevents.org

Our institute is organizing a conference in September with a fantastic list of speakers. Please share with anyone who may be interested!

Really excited for the first SMyLe Seminar Series event of 2026!

Looking forward to the opening seminar on Feb 17 at 16:30 with Dr. Máté Kiss. Hope to see many myeloid enthusiasts there and to keep the discussions going over the apero 🍷

There is still time to apply for our PhD opening!

‼️ New study alert ‼️ We are really proud to share that our latest research is finally out 📣

In this work, we explore the spatial and functional regulation of dendritic cells (DCs) within the tumor microenvironment and how these mechanisms impact #cancerprogression and response to #immunotherapy 🧵

Applications are now open for a fully-funded PhD position in my group in Frankfurt. Please share with anyone who might be interested! More info: georg-speyer-haus.de/en/karriere/...

⚠️ Half of commercial antibodies miss their target!
So how do you pick the right one for your experiment?

Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk

Tested by @ycharos.bsky.social & @oga-community.bsky.social

For our #flowcytometry peeps, would you like to have a single fix/perm protocol that is optimised for everything? One that preserves fluorophores while allowing simultaneous TF and cytokine staining? How about 100-fold cheaper?

You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...

Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition - Nature Communications Tumor-associated neutrophils exhibit heterogeneity in breast cancer. Here, the authors identify a distinct precursor population (PreNeu) in estrogen receptor-positive tumors. PreNeu suppress homologou...

🚀 Excited to share our latest publication!
👉 www.nature.com/articles/s41...
A fantastic collaboration with an incredible team.

#BreastCancer #Neutrophils #TumorMicroenvironment #PARPinhibitors #DNARepair #NatureCommunications #CancerImmunology #CalcinottoLab

I am grateful to co-lead authors Laszlo Halasz and Eva Hadadi, and everyone involved from the labs of Jo Van Ginderachter, Laszlo Nagy, and Damya Laoui (@laouimmunology.bsky.social‬).

Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment - Genome Medicine Background Monocytes are recruited to tumors and undergo transcriptional reprogramming resulting in tumor-promoting functions. Epigenomic features, such as post-translational modification of histones ...

Our new paper is out:
Tumors don’t just reprogram monocytes locally. We show in a mouse model that the systemic impact of a tumor can alter the epigenome of peripheral monocytes, repressing IFN-responsive regulatory elements and priming pro-tumor gene programs.

Happy to share that I’ll be starting my lab as a junior group leader at the Georg-Speyer-Haus in Frankfurt in 2026. We’ll study how transcriptional regulators control neutrophil function in cancer. I’ll be hiring soon (PhD/lab tech), please reach out if you know someone interested!

Congratulations Santiago!

🚨We're hiring! We've opened a fully-funded Ph.D. position to join my lab at the #LIH, if you are interested in understanding how genetic variation influences immune responses against cancer, don't hesitate to apply! 🔬 🧪

More info below ⬇️
www.lih.lu/en/job/?valu...

#cancer #immunology #genomics